Authors:
RUFFER U
EISENBARTH M
GLASER B
LENZEN S
TRALLS P
DIEHL V
FLECHTNER H
Citation: U. Ruffer et al., ASSESSMENT OF THE LIFE SITUATION AND THE QUALITY-OF-LIFE IN LONG-TERMSURVIVORS OF HODGKINS-DISEASE, Quality of life research, 6(7-8), 1997, pp. 323-323
Authors:
BARTH S
MATTHEY B
SCHON G
DIEHL V
ENGERT A
Citation: S. Barth et al., DEVELOPMENT OF A NEW RECOMBINANT ANTI-CD30 IMMUNOTOXIN (CD30L-ETA) FOR THE TREATMENT OF HODGKINS LYMPHOMA, European journal of cancer, 33, 1997, pp. 39-39
Citation: B. Matthey et al., PBM1.1, A NEW PET-BASED VECTOR FOR HIGH-EFFICIENCY EXPRESSION OF ETA FUSION TOXINS, European journal of cancer, 33, 1997, pp. 129-129
Citation: J. Wolf et al., BREAST-CANCER FOLLOWING TREATMENT OF HODGKINS-DISEASE - MORE REASONS FOR LESS RADIOTHERAPY, European journal of cancer, 33(14), 1997, pp. 2293-2294
Authors:
THIELE J
ZIRBES TK
LORENZEN J
KVASNICKA HM
SCHOLZ S
ERDMANN A
FLUCKE U
DIEHL V
FISCHER R
Citation: J. Thiele et al., HEMATOPOIETIC TURNOVER INDEX IN REACTIVE AND NEOPLASTIC BONE-MARROW LESIONS - QUANTIFICATION BY APOPTOSIS AND PCNA LABELING, Annals of hematology, 75(1-2), 1997, pp. 33-39
Authors:
HEINDEL W
DEROCHEMONT RD
KUGEL H
ERNST S
TESCH H
DIEHL V
LACKNER K
Citation: W. Heindel et al., P-31-MR SPECTROSCOPY OF THE HUMAN LIVER - SPECTRAL HINTS ON HEPATIC LYMPHOMA INFILTRATION, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 167(1), 1997, pp. 62-70
Authors:
JOX A
ROHEN C
BELGE G
BARTNITZKE S
PAWLITA M
DIEHL V
BULLERDIEK J
WOLF J
Citation: A. Jox et al., INTEGRATION OF EPSTEIN-BARR-VIRUS IN BURKITTS-LYMPHOMA CELLS LEADS TOA REGION OF ENHANCED CHROMOSOME INSTABILITY, Annals of oncology, 8, 1997, pp. 131-135
Authors:
HUBEL K
TESCH H
KROGER B
SCHNELL R
BORCHMANN P
DIEHL V
ENGERT A
Citation: K. Hubel et al., A PHASE I II STUDY OF IDARUBICIN, DEXAMETHASONE AND INTERFERON-ALPHA (I-DEXA) IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE-MYELOMA/, Leukemia, 11, 1997, pp. 47-51
Authors:
LOEFFLER M
DIEHL V
PFREUNDSCHUH M
RUHL U
HASENCLEVER D
NISTERSBACKES H
SIEBER M
TESCH H
FRANKLIN J
GEILEN W
BARTELS H
CARTONI C
DOLKEN G
ENZIAN J
FUCHS R
GASSMANN W
GERHARTZ H
HAGENAUKAMP U
HILLER E
HINKELBEIN H
HINTERBERGER W
KIRCHNER H
KOCH P
KRUGER B
KURTEN H
KUTZNER K
LOOS U
MENDE W
MULLER H
OERTEL W
PETSCH S
PFAB R
PFLUGER H
ROHLOFF R
SAUER R
SCHALK K
SCHICK HD
SCHOPPE W
SZEPESI S
TEICHMANN J
WORST P
FISCHER R
GEORGII A
HUBNER K
SCHWARZE EW
Citation: M. Loeffler et al., DOSE-RESPONSE RELATIONSHIP OF COMPLEMENTARY RADIOTHERAPY FOLLOWING 4 CYCLES OF COMBINATION CHEMOTHERAPY IN INTERMEDIATE-STAGE HODGKINS-DISEASE, Journal of clinical oncology, 15(6), 1997, pp. 2275-2287
Authors:
DREES C
GROND M
SZELIES B
DIETLEIN M
SALZBERGER B
DIEHL V
HEISS WD
Citation: C. Drees et al., POLYNEUROPATHY IN MONOCLONAL GAMMOPATHY O F UNDETERMINED SIGNIFICANCE(MGUS) - INITIAL MANIFESTATION OF A LYMPHOMA, Medizinische Klinik, 92(2), 1997, pp. 112-116
Authors:
MANZKE O
TITZER S
TESCH H
DIEHL V
BOHLEN H
Citation: O. Manzke et al., CD3-X-CD19 BISPECIFIC ANTIBODIES AND CD28 COSTIMULATION FOR LOCOREGIONAL TREATMENT OF LOW-MALIGNANCY NON-HODGKINS-LYMPHOMA, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 198-202
Authors:
FRANKE H
ENGEL C
LOEFFLER M
DIEHL V
SCHMITZ S
Citation: H. Franke et al., DOSE INTENSIFICATION OF CHEMOTHERAPY - AN ESTIMATION OF HEMATOLOGICALTOXICITY AND THE EFFECT OF DIFFERENT G-CSF ADMINISTRATION BY MODEL SIMULATION, Experimental hematology, 25(8), 1997, pp. 159-159
Authors:
SCHEID C
HINRICHS R
WINTER S
SCHULZ A
DIEHL V
WICKRAMANAYAKE PD
Citation: C. Scheid et al., T-CELL SUBPOPULATIONS AND NK FUNCTION AFTER AUTOLOGOUS PERIPHERAL PROGENITOR-CELL TRANSPLANTATION - PREFERENTIAL RECOVERY OF CELLS WITH CYTOTOXIC POTENTIAL, Experimental hematology, 25(8), 1997, pp. 284-284
Authors:
WINKLER U
RIEDER H
MARZ W
VOLIOTIS D
FRANZEN C
SCHMITZ S
REHDER H
DIEHL V
ENGERT A
Citation: U. Winkler et al., ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL CELL-LINE FROM A PATIENT WITH AN ACUTE MYELOID-LEUKEMIA, FAB M6, WITH COMPLEX CHROMOSOMAL-ABERRATIONS, Experimental hematology, 25(8), 1997, pp. 446-446
Authors:
HOMBACH A
MATHAS S
JENSEN M
TILLMANN T
MENGES M
DIEHL V
KRUIS W
POHL C
Citation: A. Hombach et al., ACTIVATION OF RESTING T-CELLS AGAINST THE CA-72-4 TUMOR-ANTIGEN WITH AN ANTI-CD3 CA-72-4 BISPECIFIC ANTIBODY IN COMBINATION WITH A COSTIMULATORY ANTI-CD28 ANTIBODY/, Anticancer research, 17(3C), 1997, pp. 2025-2032
Authors:
FATKENHEUER G
ARNOLD G
STEFFEN HM
FRANZEN C
SCHRAPPE M
DIEHL V
SALZBERGER B
Citation: G. Fatkenheuer et al., INVASIVE AMEBIASIS IN 2 PATIENTS WITH AIDS AND CYTOMEGALOVIRUS COLITIS, Journal of clinical microbiology, 35(8), 1997, pp. 2168-2169
Authors:
FRANZEN C
ALTFELD M
HEGENER P
HARTMANN P
ARENDT G
JABLONOWSKI H
ROCKSTROH J
DIEHL V
SALZBERGER B
FATKENHEUER G
Citation: C. Franzen et al., LIMITED VALUE OF PCR FOR DETECTION OF TOXOPLASMA-GONDII IN BLOOD FROMHUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS, Journal of clinical microbiology, 35(10), 1997, pp. 2639-2641
Authors:
THIELE J
ZIRBES TK
LORENZEN J
KVASNICKA HM
DRESBACH S
MANICH B
LEDER LD
NIEDERLE N
DIEHL V
FISCHER R
Citation: J. Thiele et al., APOPTOSIS AND PROLIFERATION (PCNA LABELING) IN CML - A COMPARATIVE IMMUNOHISTOLOGICAL STUDY ON BONE-MARROW BIOPSIES FOLLOWING INTERFERON AND BUSULFAN THERAPY, Journal of pathology, 181(3), 1997, pp. 316-322